FDA appoints Parks as deputy director of ODE II

Curtis Rosebraugh, director of the Office of Drug Evaluation II (ODE II) in FDA's Center for Drug Evaluation and Research (CDER), announced in an internal memo that Mary Parks will become deputy direc...